These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 20331758
1. Factor VIII/von Willebrand factor concentrate for treatment of life threatening epistaxis in Glanzmann's thrombasthenia. Zinke RA, Ornstein DL, Holmes CE. Haemophilia; 2010 Jul 01; 16(4):701-4. PubMed ID: 20331758 [No Abstract] [Full Text] [Related]
2. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa. Javed A, Ayyub M, Abrar S, Mansoor M, Khan B, Hussain T. J Ayub Med Coll Abbottabad; 2009 Jul 01; 21(2):171-3. PubMed ID: 20524499 [Abstract] [Full Text] [Related]
3. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia. Franchini M, Lippi G. Expert Rev Hematol; 2014 Dec 01; 7(6):733-40. PubMed ID: 25387838 [Abstract] [Full Text] [Related]
4. Glanzmann's thrombasthenia with mild von Willebrand's disease. Nounou R, Spence D. J Clin Pathol; 1993 Dec 01; 46(12):1134-6. PubMed ID: 8282841 [Abstract] [Full Text] [Related]
5. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Cağlar K, Cetinkaya A, Aytaç S, Gümrük F, Gürgey A. Pediatr Hematol Oncol; 2003 Sep 01; 20(6):435-8. PubMed ID: 14631616 [Abstract] [Full Text] [Related]
6. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia. van Buuren HR, Wielenga JJ. Dig Dis Sci; 2002 Sep 01; 47(9):2134-6. PubMed ID: 12353868 [Abstract] [Full Text] [Related]
10. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. d'Oiron R, Ménart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Négrier C. Thromb Haemost; 2000 May 01; 83(5):644-7. PubMed ID: 10823254 [Abstract] [Full Text] [Related]
11. Treatment and outcomes for epistaxis in children with Glanzmann's thrombasthenia. Rosas RR, Kurth MH, Sidman J. Laryngoscope; 2010 Dec 01; 120(12):2374-7. PubMed ID: 21108426 [Abstract] [Full Text] [Related]
14. Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment. Coppola A, Tufano A, Cimino E, Agangi A, Maruotti GM, Martinelli P, Di Minno G. Thromb Haemost; 2004 Dec 01; 92(6):1450-2. PubMed ID: 15583755 [No Abstract] [Full Text] [Related]
15. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy. Erduran E, Aksoy A, Zaman D. Blood Coagul Fibrinolysis; 2009 Apr 01; 20(3):215-7. PubMed ID: 19657319 [Abstract] [Full Text] [Related]
20. The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath. Ancliff P, Liesner R, Khair K, Hann I. Blood Coagul Fibrinolysis; 1999 Oct 01; 10(7):447-8. PubMed ID: 10695773 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]